Somatropin biosimilar - Pfenex

Drug Profile

Somatropin biosimilar - Pfenex

Alternative Names: hGH - Pfenex; Human growth hormone - Pfenex; PF444

Latest Information Update: 08 Sep 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pfenex
  • Class Growth hormones; Hormonal replacements
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Growth disorders

Most Recent Events

  • 30 Jun 2014 Preclinical trials in Growth disorders in USA (SC)
  • 10 Oct 2013 This programme is still active
  • 18 Jan 2010 Early research in Growth disorders in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top